Fate Therapeutics Inc
NASDAQ:FATE

Watchlist Manager
Fate Therapeutics Inc Logo
Fate Therapeutics Inc
NASDAQ:FATE
Watchlist
Price: 1.01 USD 3.4% Market Closed
Market Cap: 116.5m USD

Intrinsic Value

The intrinsic value of one FATE stock under the Base Case scenario is 0.24 USD. Compared to the current market price of 1.01 USD, Fate Therapeutics Inc is Overvalued by 76%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

FATE Intrinsic Value
0.24 USD
Overvaluation 76%
Intrinsic Value
Price
Base Case Scenario

Valuation History
Fate Therapeutics Inc

What is Valuation History?
Ask AI Assistant
What other research platforms think about FATE?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is FATE valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Fate Therapeutics Inc.

Explain Valuation
Compare FATE to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about FATE?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Fate Therapeutics Inc

Current Assets 221.3m
Cash & Short-Term Investments 215.4m
Receivables 2.1m
Other Current Assets 3.7m
Non-Current Assets 122.4m
Long-Term Investments 10.3m
PP&E 101.9m
Other Non-Current Assets 10.2m
Current Liabilities 28.1m
Accounts Payable 3.5m
Accrued Liabilities 22.3m
Other Current Liabilities 2.3m
Non-Current Liabilities 81.5m
Other Non-Current Liabilities 81.5m
Efficiency

Free Cash Flow Analysis
Fate Therapeutics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Fate Therapeutics Inc

Revenue
7.1m USD
Operating Expenses
-181.9m USD
Operating Income
-174.7m USD
Other Expenses
18.6m USD
Net Income
-156.1m USD
Fundamental Scores

FATE Profitability Score
Profitability Due Diligence

Fate Therapeutics Inc's profitability score is 17/100. The higher the profitability score, the more profitable the company is.

17/100
Profitability
Score

Fate Therapeutics Inc's profitability score is 17/100. The higher the profitability score, the more profitable the company is.

FATE Solvency Score
Solvency Due Diligence

Fate Therapeutics Inc's solvency score is 58/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Low D/E
Long-Term Solvency
Low Altman Z-Score
58/100
Solvency
Score

Fate Therapeutics Inc's solvency score is 58/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

FATE Price Targets Summary
Fate Therapeutics Inc

Wall Street analysts forecast FATE stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for FATE is 5.04 USD with a low forecast of 2.02 USD and a high forecast of 8.4 USD.

Lowest
Price Target
2.02 USD
100% Upside
Average
Price Target
5.04 USD
399% Upside
Highest
Price Target
8.4 USD
732% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Fate Therapeutics Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for FATE is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

FATE Insider Trading
Buy and sell transactions by insiders

FATE News

Other Videos
What is the Intrinsic Value of one FATE stock?

The intrinsic value of one FATE stock under the Base Case scenario is 0.24 USD.

Is FATE stock undervalued or overvalued?

Compared to the current market price of 1.01 USD, Fate Therapeutics Inc is Overvalued by 76%.

Back to Top